Advertisement

Topics

Parkinson's Disease Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10112017] Prices from USD $4600

02:52 EST 4 Dec 2017 | BioPortfolio Report Blog

DelveInsight's Parkinson's Disease Market Insights, Epidemiology and Market Forecast 2025report provides an overview of Parkinson's disease PD, epidemiology and market trend of the Parkinson's disease PD for the United States, EU5 Germany, Spain, Italy, France and United Kingdom, and Japan.


The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Parkinson's disease PD from 2017 to 2025 segmented by seven major markets. In addition, the report also includes the forecasted epidemiology of Parkinson's disease PD till 2025. It also covers market drivers, market barriers and unmet medical need.


This report provides the diagnosed cases of Parkinson's disease PD. Changes in diagnostic practice over time and increase in aging population will slowly increase the diagnosed cases of PD. According to DelveInsight, the prevalent population of Parkinson's disease PD is expected to reach up to XXX cases by the end of 2025 at a CAGR of 4.69% from 20152025. High prevalent cases were observed in United States as compared to EU5 and Japan.


The market size is driven by several approved drugs that are being used for the treatment of Parkinson's disease such as Neupro UCB Group of Companies, Xadago Newron Pharmaceuticals S.p.A. and Exelon Novartis.


United States contributes the major share of Parkinson's disease PD market as compared to EU5 countries and Japan. The therapeutic market of PD in 7MM is expected to reach USD 4.91 Billion in 2025 at the CAGR of XX% from 20152025.


Key Coverage and Benefits:


The report will help in developing business strategies by understanding the trends shaping and driving the global Parkinson's disease PD market.

Organize sales and marketing efforts by identifying the best opportunities for Parkinson's disease in US, EU5 Germany, Spain, Italy, France and United Kingdom and Japan.

To understand the future market competition in the Parkinson's disease market and Insightful review of the key market drivers and barriers.

To understand the regulatory scenario in major markets.

The report provides historical as well as forecasted epidemiology of Parkinson's disease in the 7MM covering United States, EU5 Germany, Spain, Italy, France and United Kingdom and Japan from 20152025.

The Report also covers the detailed historical and forecasted Parkinson's disease market covering United States, EU5 Germany, Spain, Italy, France and United Kingdom and Japan from 20152025.

Original Article: Parkinson's Disease Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10112017] Prices from USD $4600

NEXT ARTICLE

More From BioPortfolio on "Parkinson's Disease Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10112017] Prices from USD $4600"

Quick Search
Advertisement
 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...